Results 131 to 140 of about 3,573 (200)

A randomized, double blind, placebo-controlled pilot study to assess the efficacy of erenumab in individuals with temporomandibular disorder. [PDF]

J Oral Facial Pain Headache
Avila HC, Kroenke K, Eckert GJ, Gossweiler AG, Galvez LDC, Zero DT.   +5 more
europepmc   +1 more source

Letter to the Editor: Reaffirming Caution-The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy. [PDF]

Eur J Neurol
Gaul C, Naegel S.
europepmc   +1 more source

Erenumab for headaches in idiopathic intracranial hypertension:a prospective open-label evaluation [PDF]

, 2021
Alimajstorovic, Zerin, Edwards, Julie, Fisher, Claire, Grech, Olivia, Lavery, Gareth, Mitchell, James, Mollan, Susan, Sinclair, Alex, Vijay, Vivek, Yiangou, Andreas   +9 more
core  

Patient Adherence and Long-Term Tolerability of Anti-calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies in Migraine Prevention: A Systematic Review. [PDF]

Cureus
Ray R, Virk GS, Regmi N, Shafiq MM, Siddique R, Elfatih Elamin A, Jihad Y, Ali A, Devi H, Essani B.   +9 more
europepmc   +1 more source

Safety and efficacy of calcitonin gene-related peptide antagonists for cluster headache: a systematic review and meta-analysis. [PDF]

BMC Neurol
Khanfar R, Radwan E, Hattab S.
europepmc   +1 more source

Erenumab for Chronic Cluster Headache: A Randomized Clinical Trial. [PDF]

JAMA Netw Open
Mecklenburg J, Gaul C, Fitzek M, Overeem LH, Heinze A, Fleischmann R, Boeger A, Holle-Lee D, Straube A, Gendolla A, Israel-Willner H, Lorenz M, Gossrau G, Naegel S, Rimmele F, Rattan S, Materne B, Schulze D, Raffaelli B, Reuter U, CHERUB01 Study Group.   +20 more
europepmc   +1 more source

Estimating risk of reported versus theoretical drug-drug interactions in headaches medicine: an exhaustive comparison between DrugBank and FAERS database for abortive and preventive combinations. [PDF]

J Oral Facial Pain Headache
Kaytser V, Hakkinen I, Dave J, Zhang P.
europepmc   +1 more source

CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke: A Review. [PDF]

Neurology
Eller MT, Schwarzová K, Gufler L, Karisik A, Kaltseis K, Frank F, Broessner G.   +6 more
europepmc   +1 more source

Timing of Effect Onset After Restarting Anti CGRP-(Receptor)-Monoclonal Antibodies Following a Mandatory Cessation After One year of Use-A Single Center Retrospective Cohort Study. [PDF]

Drug Des Devel Ther
Panos LD, Scutelnic A, Plüss SE, Bracher J, Rossel JB, Branca M, Riederer F, Schankin CJ.   +7 more
europepmc   +1 more source

Prophylactic Management of Vestibular Migraine: A Systematic Review. [PDF]

Ann Clin Transl Neurol
Almohammed HA, Thalib HI, Kushara KF, Bin Saddiq BW, Al Zoabi BMK, Khan TN, Morad AS, Aljuaid RW, Gharawi LM, Alsaygh SJ, Pereira M, Abuhulayqah S.   +11 more
europepmc   +1 more source